Regenesis

Regenesis Biomedical, Inc. is a medical device company based in Scottsdale, Arizona, founded in 1996. The company focuses on improving human welfare through the research, design, manufacture, and sale of energy-based medical products aimed at tissue regenerative medicine and non-invasive pain management. Its flagship product, the FDA-cleared Provant® Therapy System, offers safe, non-drug pain management while promoting tissue regeneration. The core technology of Regenesis is Cell Proliferation Induction, which uses physical stimuli to trigger cellular responses that lead to cell replication and regeneration. This innovative approach addresses chronic wound healing and other medical needs by enhancing the body's natural healing processes. Regenesis serves a diverse range of healthcare facilities, including hospitals, rehabilitation centers, and outpatient clinics, as well as patients receiving care at home. The company is committed to values such as innovation, integrity, and compassion, and has experienced significant growth and success in the medical technology field.

• Employees 110
• Founded 1997
• Annual Revenue $11000000
• Total Funding $5827000